2018-1219 {� �} New Listing - Terranueva Corporation (TEQ)
le 14 d{� �}cembre/December 2018
The common shares of Terranueva Corporation, previously listed as Axe Exploration Inc., have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on
the trading date.
|
thecse.com
Terranueva Corporation and its subsidiary are licenses applicant under the Cannabis Act and the Cannabis Regulations. Once the licenses have been obtained from Health Canada, the focus of Terranueva is to produce medicinal and recreational cannabis in an environment
inspired by GMP pharma standards at its indoor facility located in province of Qu{� �}bec. In doing so, Terranueva will strive to deliver the highest standards of efficiency, quality and stability to its products for related therapeutic cannabis treatments such
as chronic pains, migraines, sleeping disorders or anxiety.
|
Terranueva Corporation and its subsidiary are licenses applicant under the Cannabis Act and the Cannabis Regulations. Once the licenses have been obtained from Health Canada, the focus of
Terranueva is to produce medicinal and recreational cannabis in an environment inspired by GMP pharma standards at its indoor facility located in province of Qu{� �}bec. In doing so, Terranueva will strive to deliver the highest standards of efficiency, quality
and stability to its products for related therapeutic cannabis treatments such as chronic pains, migraines, sleeping disorders or anxiety.
________________________
Les actions ordinaires de Corporation Terranueva, auparavant d{� �}sign{� �}e Axe Exploration Inc. ont {� �}t{� �} approuv{� �}es {� �} la cote du CSE.
Les documents de cotation et d'information seront disponibles sur
www.thecse.com {� �} la date de n{� �}gociation.
Corporation Terranueva et sa filiale sont des demandeurs de licences au sens de la loi sur le cannabis et du r{� �}glement sur le cannabis. Une fois que les licences ont {� �}t{� �} obtenues de Sant{� �}
Canada, Terranueva se concentre sur la production de cannabis {� �} des fins m{� �}dicales et r{� �}cr{� �}atives dans un environnement inspir{� �} par les normes GMP pharma dans ses installations int{� �}rieures situ{� �}es dans la province de Qu{� �}bec. Ce faisant, Terranueva s{� �}efforcera
de respecter les normes les plus {� �}lev{� �}es en mati{� �}re d{� �}efficacit{� �}, de qualit{� �} et de stabilit{� �} pour ses traitements th{� �}rapeutiques au cannabis, tels que les douleurs chroniques, les migraines, les troubles du sommeil ou l{� �}anxi{� �}t{� �}.
|
Issuer/{� �}metteur:
|
Terranueva Corporation
|
|
Security Type/Titre:
|
Common Shares/Actions ordinaires
|
|
Symbol(s)/Symbole(s):
|
TEQ
|
|
Number of securities issued and outstanding/ Titres {� �}mis et en circulation:
|
31 663 293
|
|
Number of Securities reserved for issuance/ Titres r{� �}serv{� �}s pour {� �}mission:
|
6 721 373
|
|
CSE Sector/Cat{� �}gorie:
|
Life Sciences/Sciences biologiques
|
|
CUSIP:
|
88105H 10 1
|
|
ISIN:
|
CA 88105H 10 1 0
|
|
Boardlot/Quotit{� �}:
|
500
|
|
Trading Currency/Monnaie de n{� �}gociation:
|
CDN$/$CDN
|
|
Trading Date/Date de negociation:
|
le 17 d{� �}cembre/December 2018
|
|
Other Exchanges/Autres marches:
|
N/A
|
|
Fiscal Year end /Cl{� �}ture de l'exercice financier:
|
Le 30 septembre/September
|
|
Transfer Agent/Agent des transferts:
|
Computershare Investor Services Inc.
|
The Exchange is accepting Market Maker applications for TEQ. Please email:
Trading@theCSE.com
If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com
Pour toute question, pour obtenir de l{� �}information suppl{� �}mentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel {� �} l{� �}adresse: Listings@thecse.com
To unsubscribe, click
here.